Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Oct 30, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc.
|
0
|
$15.52 | -$162,984.63 |
—
|
0
|
Oct 28
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -716.00 |
$30.00 | -$21,482.51 | -0.21% | 343.31K |
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -847.00 |
$30.00 | -$25,412.54 | -0.08% | 1.02M |
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -924.00 |
$30.00 | -$27,722.68 | -0.09% | 1M |
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$16.24 | -$22,403.72 |
—
|
0
|
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.57K |
$30.00 | -$47,104.03 | -1.03% | 150.84K |
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$16.24 | -$22,458.77 |
—
|
0
|
Oct 18
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$27.67 | -$35,143.31 | -1.01% | 124.49K |
Oct 15
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$15.01 | -$13,054.80 |
—
|
0
|
Oct 1
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$22.41 | -$28,458.16 | -0.97% | 129.1K |
Sep 16
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -12.00K |
$22.49 | -$269,841.38 | -1.10% | 1.08M |
Aug 29
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.51 | -$85,241.82 |
—
|
0
|
Aug 27
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -12.00K |
$22.89 | -$274,718.40 | -1.13% | 1.05M |
Aug 26
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$23.25 | -$29,526.20 | -0.96% | 130.37K |
Aug 15
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -3.10K |
$27.56 | -$85,399.45 | -0.28% | 1.09M |
Jul 31
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -2.27K |
$27.56 | -$62,555.07 | -0.21% | 1.06M |
Jul 31
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$15.01 | -$24,823.26 |
—
|
0
|
Jul 31
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -2.35K |
$27.51 | -$64,662.54 | -1.45% | 159.56K |
Jul 31
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -12.00K |
$26.70 | -$320,377.80 | -1.09% | 1.09M |
Jul 29
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$14.58 | -$127,032.21 |
—
|
0
|
Jul 29
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$24.80 | -$31,496.76 | -0.94% | 133.34K |
Jul 15
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -50.00K |
$25.06 | -$1,252,826.10 | -12.69% | 344.03K |
Jul 12 - Jul 16
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$13.78 | -$67,755.00 |
—
|
0
|
Jul 12
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -12.00K |
$22.89 | -$274,736.40 | -1.07% | 1.11M |
Jul 1
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.53 | -$85,381.55 |
—
|
0
|
Jun 27
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -12.00K |
$21.66 | -$259,901.54 | -1.10% | 1.08M |
Jun 25
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$21.48 | -$27,277.95 | -0.93% | 134.62K |
Jun 17
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$11.27 | -$19,912.59 |
—
|
0
|
Jun 6
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$11.43 | -$247,360.14 |
—
|
0
|
May 29
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.15 | -$264,770.05 |
—
|
0
|
May 28
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.83 | -$87,990.29 |
—
|
0
|
May 28
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.27K |
$23.74 | -$30,149.67 | -0.93% | 135.88K |
May 16
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
| -1.03M |
$22.14 | -$22,877,262.00 | -11.54% | 7.92M |
May 16
| |||||||
Enliven Therapeutics, Inc.
| -1.03M |
$22.14 | -$22,877,262.00 | -11.54% | 7.92M |
May 16
| |||||||
Enliven Therapeutics, Inc.
|
0
|
$13.74 | -$24,929.64 |
—
|
0
|
May 14
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$13.77 | -$5,870.70 |
—
|
0
|
May 9
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.60 | -$98,679.26 |
—
|
0
|
May 6
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$12.49 | -$20,020.00 |
—
|
0
|
May 3
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$9.52 | -$201,547.75 |
—
|
0
|
Apr 29
|
Scheduled
| ||||||
Enliven Therapeutics, Inc.
|
0
|
$9.73 | -$47,104.52 |
—
|
0
|
Apr 29
|
Scheduled
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.